Sudeep Pharma Limited (NSE:SUDEEPPHRM)

Market Cap	83.82B
Revenue (ttm)	6.42B +46.1%
Net Income	1.73B +29.8%
EPS	15.50 +26.2%
Shares Out	112.95M
PE Ratio	47.88
Forward PE	43.40
Dividend	1.50 (0.20%)
Ex-Dividend Date	n/a

Volume	1,795,503
Open	772.85
Previous Close	742.15
Day's Range	755.10 - 816.35
52-Week Range	524.05 - 816.35
Beta	n/a
Analysts	Sell
Price Target	663.50 (-14.99%)
Earnings Date	May 21, 2026

About Sudeep Pharma

Sudeep Pharma Limited manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in United States, Europe, United Kingdom, and Latin America. The company provides mineral salts, such as calcium, zinc, iron, potassium, magnesium, sodium, and copper to a range of health-focused applications; and calcium carbonate, which is used as an active pharmaceutical ingredient for various therapeutic applications. It also offers micronutrient premixes, encapsulated ingredients, liposomal and spray-drie...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 740
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SUDEEPPHRM

Financial Performance

In fiscal year 2026, Sudeep Pharma's revenue was 6.42 billion, an increase of 27.94% compared to the previous year's 5.02 billion. Earnings were 1.73 billion, an increase of 24.63%.